Spectral Medical Inc. (EDTXF)
USD 0.58
(0.1%)
USD 0.58
(0.1%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -13.95 Million CAD | -22.28% |
| 2022 | -7.7 Million CAD | -10.36% |
| 2021 | -6.37 Million CAD | 5.44% |
| 2020 | -8.76 Million CAD | -98.22% |
| 2019 | -4.43 Million CAD | -224.45% |
| 2018 | -1.88 Million CAD | 53.52% |
| 2017 | -3.16 Million CAD | 67.43% |
| 2016 | -9.23 Million CAD | -1.17% |
| 2015 | -8.9 Million CAD | 4.53% |
| 2014 | -9.39 Million CAD | 12.1% |
| 2013 | -10.64 Million CAD | -33.13% |
| 2012 | -8 Million CAD | -23.54% |
| 2011 | -6.46 Million CAD | -10.54% |
| 2010 | -5.72 Million CAD | -201.81% |
| 2009 | -1.93 Million CAD | -80.35% |
| 2008 | -1.07 Million CAD | 5.54% |
| 2007 | -1.13 Million CAD | -19.94% |
| 2006 | -948 Thousand CAD | 78.07% |
| 2005 | -3.57 Million CAD | -9.44% |
| 2004 | -4.32 Million CAD | -31.14% |
| 2003 | -3.95 Million CAD | -63.78% |
| 2002 | -3.01 Million CAD | 53.32% |
| 2001 | -1.83 Million CAD | 19.59% |
| 2000 | -3.94 Million CAD | 47.87% |
| 1999 | -4.9 Million CAD | 16.81% |
| 1998 | -9.4 Million CAD | 2.59% |
| 1997 | -11.6 Million CAD | 14.71% |
| 1996 | -11.6 Million CAD | -29.52% |
| 1995 | -13.6 Million CAD | -123.4% |
| 1994 | -10.5 Million CAD | -62.07% |
| 1993 | -4.7 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.18 Million CAD | 27.28% |
| 2024 Q2 | -4.03 Million CAD | -84.24% |
| 2023 Q3 | -2.88 Million CAD | 27.55% |
| 2023 FY | - CAD | -22.28% |
| 2023 Q4 | -3.01 Million CAD | -4.33% |
| 2023 Q1 | -1.6 Million CAD | -114.13% |
| 2023 Q2 | -3.98 Million CAD | -147.95% |
| 2022 Q1 | -2.6 Million CAD | -4.7% |
| 2022 Q2 | -2.78 Million CAD | -6.87% |
| 2022 Q3 | -3.02 Million CAD | -8.69% |
| 2022 FY | - CAD | -10.36% |
| 2022 Q4 | -750 Thousand CAD | 75.22% |
| 2021 Q2 | -2.22 Million CAD | -43.04% |
| 2021 FY | - CAD | 5.44% |
| 2021 Q4 | -2.48 Million CAD | -21.65% |
| 2021 Q3 | -2.04 Million CAD | 7.84% |
| 2021 Q1 | -1.55 Million CAD | 19.59% |
| 2020 Q2 | -1.64 Million CAD | 56.94% |
| 2020 FY | - CAD | -98.22% |
| 2020 Q4 | -1.93 Million CAD | -39.86% |
| 2020 Q1 | -3.82 Million CAD | -195.75% |
| 2020 Q3 | -1.38 Million CAD | 16.26% |
| 2019 Q2 | -910 Thousand CAD | -4.48% |
| 2019 Q1 | -871 Thousand CAD | -197.32% |
| 2019 Q4 | -1.29 Million CAD | 4.64% |
| 2019 FY | - CAD | -224.45% |
| 2019 Q3 | -1.35 Million CAD | -49.12% |
| 2018 Q1 | -560 Thousand CAD | 29.2% |
| 2018 FY | - CAD | 53.52% |
| 2018 Q4 | 895 Thousand CAD | 284.54% |
| 2018 Q3 | -485 Thousand CAD | 60.08% |
| 2018 Q2 | -1.21 Million CAD | -116.96% |
| 2017 Q4 | -791 Thousand CAD | -48.68% |
| 2017 Q1 | -755 Thousand CAD | -45.75% |
| 2017 Q2 | -861 Thousand CAD | -14.04% |
| 2017 Q3 | -532 Thousand CAD | 38.21% |
| 2017 FY | - CAD | 67.43% |
| 2016 Q1 | -2.79 Million CAD | -24.6% |
| 2016 Q2 | -3.31 Million CAD | -18.6% |
| 2016 Q4 | -518 Thousand CAD | 78.44% |
| 2016 Q3 | -2.4 Million CAD | 27.4% |
| 2016 FY | - CAD | -1.17% |
| 2015 Q2 | -2.21 Million CAD | -2.5% |
| 2015 Q1 | -2.15 Million CAD | 5.89% |
| 2015 FY | - CAD | 4.53% |
| 2015 Q4 | -2.24 Million CAD | 3.16% |
| 2015 Q3 | -2.31 Million CAD | -4.66% |
| 2014 Q4 | -2.29 Million CAD | -23.7% |
| 2014 Q1 | -2.95 Million CAD | 14.87% |
| 2014 Q2 | -2.24 Million CAD | 24.06% |
| 2014 Q3 | -1.85 Million CAD | 17.47% |
| 2014 FY | - CAD | 12.1% |
| 2013 Q1 | -1.88 Million CAD | 1.77% |
| 2013 Q4 | -3.47 Million CAD | -47.58% |
| 2013 Q3 | -2.35 Million CAD | 19.34% |
| 2013 Q2 | -2.91 Million CAD | -54.45% |
| 2013 FY | - CAD | -33.13% |
| 2012 Q4 | -1.92 Million CAD | -0.95% |
| 2012 FY | - CAD | -23.54% |
| 2012 Q3 | -1.9 Million CAD | 6.99% |
| 2012 Q2 | -2.04 Million CAD | 2.99% |
| 2012 Q1 | -2.11 Million CAD | -8.09% |
| 2011 Q4 | -1.95 Million CAD | -21.92% |
| 2011 Q2 | -1.64 Million CAD | -25.21% |
| 2011 FY | - CAD | -10.54% |
| 2011 Q1 | -1.31 Million CAD | 28.77% |
| 2011 Q3 | -1.6 Million CAD | 2.91% |
| 2010 Q4 | -1.84 Million CAD | -61.34% |
| 2010 Q2 | -1.09 Million CAD | 37.55% |
| 2010 FY | - CAD | -201.81% |
| 2010 Q1 | -1.75 Million CAD | -69.08% |
| 2010 Q3 | -1.14 Million CAD | -4.56% |
| 2009 Q3 | -261 Thousand CAD | 33.92% |
| 2009 Q1 | -200 Thousand CAD | 27.27% |
| 2009 Q2 | -395 Thousand CAD | -97.5% |
| 2009 FY | - CAD | -80.35% |
| 2009 Q4 | -1.03 Million CAD | -297.7% |
| 2008 Q1 | -353 Thousand CAD | 42.97% |
| 2008 Q4 | -275 Thousand CAD | -22.22% |
| 2008 Q3 | -225 Thousand CAD | -6.64% |
| 2008 Q2 | -211 Thousand CAD | 40.23% |
| 2008 FY | - CAD | 5.54% |
| 2007 FY | - CAD | -19.94% |
| 2007 Q2 | -257 Thousand CAD | -179.35% |
| 2007 Q4 | -619 Thousand CAD | -178.83% |
| 2007 Q3 | -222 Thousand CAD | 13.62% |
| 2007 Q1 | -92 Thousand CAD | 0.0% |
| 2006 FY | - CAD | 78.07% |
| 2006 Q2 | -336 Thousand CAD | 76.19% |
| 2006 Q1 | -1.41 Million CAD | -57.48% |
| 2006 Q3 | -255 Thousand CAD | 24.11% |
| 2005 Q3 | -613 Thousand CAD | 23.18% |
| 2005 Q4 | -896 Thousand CAD | -46.17% |
| 2005 FY | - CAD | -9.44% |
| 2005 Q1 | -865 Thousand CAD | 40.75% |
| 2005 Q2 | -798 Thousand CAD | 7.75% |
| 2004 Q1 | -1.19 Million CAD | -34.87% |
| 2004 FY | - CAD | -31.14% |
| 2004 Q4 | -1.46 Million CAD | -18.6% |
| 2004 Q3 | -1.23 Million CAD | -60.08% |
| 2004 Q2 | -769 Thousand CAD | 35.86% |
| 2003 FY | - CAD | -63.78% |
| 2003 Q2 | -412 Thousand CAD | 75.55% |
| 2003 Q3 | -897 Thousand CAD | -117.72% |
| 2003 Q4 | -889 Thousand CAD | 0.89% |
| 2003 Q1 | -1.68 Million CAD | -13061.54% |
| 2002 FY | - CAD | 53.32% |
| 2002 Q4 | 13 Thousand CAD | 103.56% |
| 2002 Q3 | -365 Thousand CAD | 44.95% |
| 2002 Q2 | -663 Thousand CAD | 26.09% |
| 2002 Q1 | -897 Thousand CAD | 36.29% |
| 2001 FY | - CAD | 19.59% |
| 2001 Q1 | -865 Thousand CAD | -184.54% |
| 2001 Q2 | 1.88 Million CAD | 318.27% |
| 2001 Q3 | -1.23 Million CAD | -165.15% |
| 2001 Q4 | -1.4 Million CAD | -14.47% |
| 2000 FY | - CAD | 47.87% |
| 2000 Q3 | -1.47 Million CAD | -13.62% |
| 2000 Q4 | -304 Thousand CAD | 79.42% |
| 2000 Q1 | -600 Thousand CAD | 14.29% |
| 2000 Q2 | -1.3 Million CAD | -116.67% |
| 1999 Q2 | -1.6 Million CAD | -7.14% |
| 1999 Q4 | -700 Thousand CAD | 63.16% |
| 1999 FY | - CAD | 16.81% |
| 1999 Q1 | -1.4 Million CAD | 39.13% |
| 1999 Q3 | -1.9 Million CAD | -26.67% |
| 1998 Q3 | -3.7 Million CAD | -54.17% |
| 1998 Q4 | -2.3 Million CAD | 37.84% |
| 1998 Q2 | -2.4 Million CAD | 7.69% |
| 1998 Q1 | -2.6 Million CAD | 13.33% |
| 1998 FY | - CAD | 2.59% |
| 1997 FY | - CAD | 14.71% |
| 1997 Q4 | -3 Million CAD | -7.14% |
| 1997 Q3 | -2.8 Million CAD | 3.45% |
| 1997 Q1 | -3.5 Million CAD | -20.69% |
| 1997 Q2 | -2.9 Million CAD | 17.14% |
| 1996 Q1 | -2.8 Million CAD | 26.32% |
| 1996 Q4 | -2.9 Million CAD | -11.54% |
| 1996 FY | - CAD | -29.52% |
| 1996 Q3 | -2.6 Million CAD | 0.0% |
| 1996 Q2 | -2.6 Million CAD | 7.14% |
| 1995 FY | - CAD | -123.4% |
| 1995 Q4 | -3.8 Million CAD | 7.32% |
| 1995 Q1 | -3.7 Million CAD | -76.19% |
| 1995 Q3 | -4.1 Million CAD | -20.59% |
| 1995 Q2 | -3.4 Million CAD | 8.11% |
| 1994 Q1 | -1.5 Million CAD | -15.38% |
| 1994 Q3 | -2.7 Million CAD | -58.82% |
| 1994 Q4 | -2.1 Million CAD | 22.22% |
| 1994 FY | - CAD | -62.07% |
| 1994 Q2 | -1.7 Million CAD | -13.33% |
| 1993 Q4 | -1.3 Million CAD | -18.18% |
| 1993 FY | - CAD | 0.0% |
| 1993 Q1 | -601.25 Thousand CAD | 5.84% |
| 1993 Q3 | -1.1 Million CAD | -83.33% |
| 1993 Q2 | -600 Thousand CAD | 0.21% |
| 1992 Q3 | -998.25 Thousand CAD | -178.18% |
| 1992 Q2 | -358.85 Thousand CAD | 0.0% |
| 1992 Q4 | -638.54 Thousand CAD | 36.03% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -1099.914% |
| Arrayit Corporation | -3.07 Million USD | -353.453% |
| Atlantic International Corp. | -5.38 Million USD | -158.927% |
| Biocept, Inc. | -30.24 Million USD | 53.854% |
| Bioqual, Inc. | 3.03 Million USD | 560.221% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -1742.548% |
| DermTech, Inc. | -97.89 Million USD | 85.745% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.479% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 31.061% |
| iMD Companies, Inc. | -154.65 Thousand USD | -8923.077% |
| IDenta Corp. | 71.58 Thousand USD | 19593.763% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 463.696% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 36168.752% |
| InVitro International | 6680.00 USD | 209007.186% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | -156.714% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -114907.417% |
| Medical Imaging Corp. | -896.74 Thousand USD | -1456.189% |
| NovelStem International Corp. | -3.78 Million USD | -268.614% |
| Optigenex Inc. | -1.18 Million USD | -1075.926% |
| PharmChem, Inc. | 1.05 Million USD | 1424.243% |
| Proteome Sciences plc | -1.13 Million USD | -1127.353% |
| Response Genetics, Inc | -19.66 Million USD | 29.04% |
| Rennova Health, Inc. | -234.81 Thousand USD | -5842.976% |
| RushNet, Inc. | -614.85 Thousand USD | -2169.652% |
| ScreenPro Security Inc. | -3.43 Million USD | -306.272% |
| Stella Diagnostics Inc. | -5.7 Million USD | -144.506% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | -35.879% |
| Todos Medical Ltd. | -9.39 Million USD | -48.552% |